After launching in 2016 with GP internal capital, Oceanpine announced a final closing of its Oceanpine Capital Fund II totaling $400 million.
The Beijing-based firm invests in the DeepTech arena and innovative growth companies in both TMT and biotechnology sectors that have been so popular as of late. Its inaugural fund launched with $400 million with founder capital.
Investors in the second fund includes institutional investors from the U.S. and Asia, including insurance companies, technology leaders, family . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.